Table 1. Select Treatment-Related Adverse Events of Gilteritinib.

Adverse event	Any grade	Grade 3–4
Arthralgia/myalgia	42%	5%
Dizziness	20%	< 1%
Dyspnea	34%	12%
Edema	34%	2%
Fatigue	40%	5%
Noninfectious diarrhea	34%	3%
Pneumonia	30%	23%
Rash	30%	3%
Transaminitis	41%	16%